LY-503430 is an ampakine drug developed by Eli Lilly.LY-503430 produces both nootropic and neuroprotective effects reducing brain damage caused by 6-hydroxydopamine or MPTP and also increasing levels of the neurotrophic factor BDNF in the brain particularly in the substantia nigra hippocampus and striatum.
This page contains content from the copyrighted Wikipedia article "LY-503430"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
